BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18259035)

  • 1. Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women.
    Wassertheil-Smoller S; Kooperberg C; McGinn AP; Kaplan RC; Hsia J; Hendrix SL; Manson JE; Berger JS; Kuller LH; Allison MA; Baird AE
    Hypertension; 2008 Apr; 51(4):1115-22. PubMed ID: 18259035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
    Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
    Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
    J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lipoprotein-associated phospholipase A
    Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
    Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmö, Sweden.
    Persson M; Berglund G; Nelson JJ; Hedblad B
    Atherosclerosis; 2008 Sep; 200(1):191-8. PubMed ID: 18201705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA.
    Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Kasner SE
    Stroke; 2009 Jul; 40(7):2332-6. PubMed ID: 19461040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.
    Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
    Cerebrovasc Dis; 2009; 27(1):42-50. PubMed ID: 19018137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in stroke risk prediction: role of C-reactive protein and lipoprotein-associated phospholipase A2 in the women's health initiative.
    Wassertheil-Smoller S; McGinn A; Allison M; Ca T; Curb D; Eaton C; Hendrix S; Kaplan R; Ko M; Martin LW; Xue X
    Int J Stroke; 2014 Oct; 9(7):902-9. PubMed ID: 23088183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.
    Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD
    J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study.
    Nambi V; Hoogeveen RC; Chambless L; Hu Y; Bang H; Coresh J; Ni H; Boerwinkle E; Mosley T; Sharrett R; Folsom AR; Ballantyne CM
    Stroke; 2009 Feb; 40(2):376-81. PubMed ID: 19095974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase A2 in patients with noncardioembolic ischemic stroke and severe inflammatory reaction.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Iliescu I; Dumitrescu L; Burcin C; Gurban CV; Sfrijan F
    Rom J Intern Med; 2009; 47(1):61-5. PubMed ID: 19886071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study.
    Ogorodnikova AD; Wassertheil-Smoller S; Mancuso P; Sowers MR; Rajpathak SN; Allison MA; Baird AE; Rodriguez B; Wildman RP
    Stroke; 2010 Jul; 41(7):1376-81. PubMed ID: 20508194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2 and risk of stroke.
    Gorelick PB
    Am J Cardiol; 2008 Jun; 101(12A):34F-40F. PubMed ID: 18549870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.
    Oei HH; van der Meer IM; Hofman A; Koudstaal PJ; Stijnen T; Breteler MM; Witteman JC
    Circulation; 2005 Feb; 111(5):570-5. PubMed ID: 15699277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.
    Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J
    Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Lp-PLA₂ activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapy.
    Paik JK; Kim M; Kim M; Yen Y; Ahn HY; Lee SH; Lee JH
    Age (Dordr); 2015; 37(2):32. PubMed ID: 25840804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between lipoprotein-associated phospholipase A
    Zhou F; Liu Y; Shi H; Huang Q; Zhou J
    Neurol Sci; 2018 Sep; 39(9):1591-1596. PubMed ID: 29938341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.